* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Application Note #14 - GE Healthcare Life Sciences
Artificial gene synthesis wikipedia , lookup
Matrix-assisted laser desorption/ionization wikipedia , lookup
Expression vector wikipedia , lookup
Community fingerprinting wikipedia , lookup
Magnesium transporter wikipedia , lookup
Interactome wikipedia , lookup
Mass spectrometry wikipedia , lookup
Size-exclusion chromatography wikipedia , lookup
Point mutation wikipedia , lookup
Ancestral sequence reconstruction wikipedia , lookup
Metabolomics wikipedia , lookup
Peptide synthesis wikipedia , lookup
Metalloprotein wikipedia , lookup
Amino acid synthesis wikipedia , lookup
Gel electrophoresis wikipedia , lookup
Homology modeling wikipedia , lookup
Biosynthesis wikipedia , lookup
Protein–protein interaction wikipedia , lookup
Genetic code wikipedia , lookup
Two-hybrid screening wikipedia , lookup
Biochemistry wikipedia , lookup
Western blot wikipedia , lookup
Ribosomally synthesized and post-translationally modified peptides wikipedia , lookup
A M E R S H A M B I O S C I E N C E S PrIME Purification of Recombinant Hirudin Contributed by: Pier Giorgio Righetti1, Alessandra Bossi1, Carlo Visco2, Umberto Breme2, Maurizio Mauriello2, Barbara Valsasina2, Gaetano Orsini2 and Elisabeth Wenisch3 University of Milano, L.I.T.A., Via Fratelli Cervi 93, Segrate 20090, Milano 1 Amersham Biosciences via Giovanni XXIII, I-20014 Nerviano (Italy) Application Note #14 IsoPrime® 15 1 Val Ser Tyr Thr Asp Cys Thr Glu Ser Gly Gln Asn Tyr Cys Leu 2 University of Forestry and Agriculture, Vienna, Austria 3 Keywords: PrIME, IsoPrime, Hirudin, Preparative Isoelectric Focusing, Protein Purification Introduction Hirudin is a potent and selective inhibitor of thrombin, a serine protease required for blood clotting. More than twenty highly similar isoforms of hirudin have been isolated from leeches belonging to the Hirudinidae family [1]. Because of its therapeutic potential, we studied the problem of protein micro-heterogeneity in a novel recombinant hirudin variant, HM2, from the Asian leech Hirudinaria manillensis [2], produced in Escherichia coli. Therapeutic application of recombinant proteins requires extensive characterization of purity and identification of protein micro-heterogeneities which can occur during biosynthesis, within the producing cells, or during the downstream purification process [3]. Here we describe the use of analytical and preparative immobilized pH gradient and pH membrane techniques in the identification and isolation of a number of minor degradation derivatives of HM2 for further characterization by HPLC, mass spectrometry, sequence analysis, and peptide mapping. Results Recombinant hirudin variant HM2 was expressed in E. coli as an OmpA leader peptide-HM2 fusion protein. The primary translation product was exported into the bacterial periplasmic compartment and processed by endogenous leader peptidase I to release the mature form of HM2—64 amino acid residues with three disulfide bonds (Figure 1). A simple purification protocol with two column chromatography steps gave a preparation of HM2 more than 95% pure, as demonstrated by RP-HPLC [2]. Analytical IPG-IEF on slab gels (Figure 2 B, lane 1), revealed the major band of HM2 at pI 4.03 and four minor bands, three more basic (pI 80-6383-24 Rev A / 6-97 e 30 16 Cys Val Gly Ser Asn Val Cys Gly Glu Gly Lys Asn Cys Gln Leu a 45 31 Ser Ser Ser Gly Asn Gln Cys Val His Gly Glu Gly Thr Pro Lys c 60 46 Pro Lys Ser Gln Thr Glu Gly Asp Phe Glu Glu Ile Pro Asp Glu 61 64 Asp Ile Leu Asn b Figure 1. Primary sequence of HM2. Recombinant hirudin variant HM2 is a polypeptide of 64 amino acids with disulfide bonds between Cys6-Cys14, Cys16-Cys28 and Cys22-Cys37. The positions of proteolytic cleavages are indicated with arrows. of 4.10, 4.25 and 4.31) and one more acidic (pI 3.98). PrIME (preparative isoelectric membrane electrophoresis) separation of HM2 components was carried out in a multi-compartment electrolyzer ( IsoPrime) set up with pI-selective membranes having defined pHs of 3.0, 4.0, 4.19 and 5.0. The two more basic forms were isolated in a single PrIME fraction (Figure 2 B, lane 4), and then separated further by RP-HPLC. The two contaminants remaining with the correct HM2 product were separated by micro-preparative IPG-IEF on slab gels with an immobilized pH gradient from pH 3.5 to pH 4.3 (Figure 2 A). The four isolated contaminant forms were analyzed by a combination of RP-HPLC, mass spectrometry, peptide mapping and limited proteolysis experiments. The major contaminant was the more acidic component e (pI 3.98), approximately 3% of the main protein HM2, the other three impurities were each ² 0.5% (Figure 3, upper panel). N-terminal sequence analysis of component e produced the sequence: Tyr3-Thr-Asp-, indicating the loss of the first two residues from the HM2 molecule. Mass spectrometry of component e gave a molecular mass of 6610 Da, matching the calculated value for a protein consisting of residues 3 through 64 of HM2. N-terminal sequence analysis of component a (pI 4.31) produced the sequence Val17-Gly-Ser-Asn-Val-, Val being at position 17 of the HM2 chain. Cleavage at position 47 with trypsin followed by RP-HPLC separation of the two resulting peptides yielded a fragment whose sequence was found to match the C-terminal sequence from positions 48 to 64. Finally, mass measurements of component a gave a mass of 5032 Da, corresponding to the calculated mass of the peptide chain 17-64 of HM2. Component b (pI 4.25) had the correct N-terminal sequence of HM2: Val1-Ser-Tyr-Thr-Asp-; however, the mass was 6212 Da, 585 Da less than full length HM2, suggesting the loss of the last five carboxy-terminal residues. Selective trypsin cleavage at position 47 followed by complete sequencing of the resulting C-terminal fragment gave the sequence from residue 48 to 59, confirming that component b corresponded to the peptide chain 1-59 of HM2 (Figure 4). The N-terminal sequence of component c (pI 4.10) was Val38His-Gly-Gln-, Val being at position 38 of the HM2 chain. ES-MS analysis gave a mass value of 2980 Da, corresponding to the peptide chain 38-64 of HM2. Figure 2. Isoelectric focusing of recombinant hirudin variant HM2 on immobilized pH gradients. Panel B: Analytical separation of HM2 (pI 4.03) in the pI range 3.60-4.50 showed four minor components (lane 1). Separation in the IsoPrime unit (lanes 2, 3 and 4, corresponding to chambers 1, 2 and 3 respectively) yielded the two more basic species a (pI 4.31) and b (pI 4.25) in one chamber, well resolved from the principal full length form. Panel A: A micro-preparative slab gel, spanning the pH range of 3.50-4.30, was used to separate the other two minor species c (pI 4.10) and e (pI 3.98). Discussion Heterologous recombinant proteins produced in E. coli can undergo intracellular proteolysis by action of cytoplasmic proteinases. Mass spectrometry has recently proven to be an important methodology for characterizing peptides and proteins, particularly when combined with other techniques, such as gel electrophoresis and amino acid sequence analysis [4]. The coupling of SDS-denaturing gel separation of proteins with matrix-assisted laser-desorption time-of-flight mass spectrometry (MALDI-TOF-MS) techniques has been described for proteins blotted onto a membrane [5, 6], and proteins extracted from agarose gel slices [7]. However, in these applications, essentially the same information, the molecular mass of the protein, was provided by two different methods. The approach described here, IPG followed by MS, characterizes protein variants by both isoelectric point (pI) and molecular mass, a true 2-D technique, giving the most accurate values for pI and mass. 3 examples of this phenomenon. Full length hirudin has a pI of 4.03: Component a (pI 4.31, amino acids 17-64) lost a stretch of 16 amino acids from the N-terminus containing 2 acidic residues (Asp and Glu). Its pI increased to 4.31, a DpI of +0.14/acidic residue; ● Component b (pI 4.25, amino acids 1-59) lost a pentapeptide at the C-terminus containing 2 acidic residues (Asp and Glu). Its pI increased to 4.25, a DpI of +0.11/acidic residue; and ● Component c (pI 4.10, amino acids 38-64) lost a stretch of 37 amino acids from the N-terminus containing 1 Asp, 2 Glu and 1 Lys. Here the DpI is rather minute: +0.07 because, at pH = pI, it takes more than two Glu residues to neutralize one Lys since the Glu is only partially ionized. ● The present data highlight one important mechanism of postsynthetic protein modification leading to a higher pI form. While a variety of modifications leading to lower pI species are well documented in the literature, no mechanisms leading to generation of higher pI forms from a parent macromolecule have been advanced so far. It is now evident from our data that at least one clear mechanism can be identified: proteolytic cleavage. The hirudin contaminants presented Because component e (pI 3.98, amino acids 3-64) lost only a neutral dipeptide at the N-terminus (Val-Ser), the small negative DpI must be ascribed to minute pK variations of some charged residues in the native structure. 2 Conclusion d 100 Absorbance at 215 nm The use of preparative and micro-preparative isoelectric focusing techniques using pI-selective membranes (PrIME) and immobilized pH gradient gels for protein purification in combination with conventional chromatography, mass spectrometry and amino acid sequencing is a powerful means of elucidating the nature of protein modifications. This knowledge is very valuable in the genetic engineering of host strains and the design of larger scale production and purification processes. 80 60 40 20 b c e a 0 0 10 20 30 40 50 60 Time (min) Materials and methods 100 Absorbance at 215 nm Reversed-phase high pressure liquid chromatography (RP-HPLC) RP-HPLC was performed on a Hewlett-Packard 1090M liquid chromatographic system with a Vydac 218TP C18 column, 4.6 x 250 mm, (The Separation Group, Hesperia, CA, USA). Mobile phases A and B were H2O and acetonitrile containing, respectively, 0.1 and 0.078 % trifluoroacetic acid. A linear gradient from 18 to 26% of phase B was applied over 46 min at a flow rate of 0.45 ml/min. The elution profile was monitored with a Hewlett-Packard 1040A diode array detector at 215 nm. a 80 e b c 60 40 20 0 0 10 20 30 40 50 60 Time (min) Electro-spray mass spectrometry Figure 3. Analytical RP-HPLC of hirudin variant HM2 and its degraded derivatives. Elution profile of HM2 preparation (upper panel) showed the main peak of HM2 (peak d, approximately 95% of total peak area) and its degraded components (peaks b, c, e and a). The degradation products, after separation by IEF on IPGs, were analyzed by RP-HPLC as shown in the lower panel. Molecular mass measurements were performed on a HP 5989 A MS-Engine single quadrupole instrument equipped with a HP 59987 A electro-spray interface (Hewlett Packard, Wilmington, DE, USA). Samples recovered from the IsoPrime multi-compartment electrolyzer or from micro-preparative IPG gels were diluted with 50% methyl alcohol-H2O containing 1% acetic acid and injected into the ion source at a flow rate of 2-5 µl/min. The electro-spray potential was approximately 6 kV; the quadrupole mass analyzer was set to scan over mass-to-charge ratios (m/z) from 1000 to 1700 at 2 s per scan for a total time of 10-12 s. The sum of data acquired over this time constituted the final spectrum. Molecular masses were calculated from several multiply charged ions within a coherent series. Calibrations were performed with horse skeletal muscle myoglobin. Standard manufacturer’s procedures and programs were used with minor modifications. Immobilized pH gradients (IPG) IEF in IPG was performed on an Amersham Biosciences Multiphor® II flatbed electrophoresis unit. Gels contained 5%T, 4%C and spanned the intervals pH 3.6-4.5 or pH 3.5-4.3. The formulations for these IPG ranges were from Righetti [8]. After polymerization, the gels were washed, dried and re-swollen in 20% glycerol. Gels were run for 2 h at 400 V, then 12 h at 2000 V, 10 °C. Since hirudin is very poorly stained with Coomassie Blue R-250, at the end of the run the gels were blotted onto PVDF membranes and stained with Ponceau S. Hirudin and its minor isoforms appeared as intense red/pinkish zones on a white background. Sequence analysis N-terminal sequence analysis was performed by automated Edman degradation using a pulsed liquid-phase sequencer model 477 A with an on-line analyzer model 120 A (PerkinElmer/Applied Biosystems, Foster City, CA, USA ) for the detection of phenylthiohydantoin derivatives of amino acids. 3 Preparative purification in the IsoPrime apparatus Purification of hirudin from its minor isoforms was performed on a prototype of the IsoPrime [9,10]. Four isoelectric membranes were made having pH values 3.00, 4.00, 4.19, and 5.00. Calculation of the amounts of buffering and titrant acrylamido compounds was performed with the program of Giaffreda et al. [11] (Dr. pH, included with the IsoPrime). All membranes were 10%T, 4%C polyacrylamide gels cast on Whatman GF/D filters, 4.7 cm diameter, approximately 1 mm thick. After washing the membranes three times for 20 min each time in distilled water, the IsoPrime separation unit was assembled and 7 ml of hirudin was loaded in a single chamber at the anodic side. The anolyte was 10 mM acetic acid (pH 2.88; conductivity, 85.5 µmhos) and the catholyte 50 mM isoelectric His (pH 7.47; conductivity 67.4 µmhos). Only the contents of anolyte and catholyte chambers were recycled, those from 200 ml reservoirs. No circulation reservoirs were connected to the other separation chambers because of the small amount of protein processed. Focusing of the minor isoforms of hirudin was run overnight at 600 V. Joule heat was dissipated in the cold room (7 °C). Under these conditions, the temperature rise of the liquid in the separation chamber was only 1 °C at steady-state. Absorbance at 220 nm 64 32 0 15 25 35 Time (min) Figure 4. Limited trypsin proteolysis of HM2 and component b. Selective trypsin cleavage of HM2 (profile B) gave fragments 1-47 and 48-64 while selective cleavage of component b gave the same fragment 1-47 and the new fragment 48-59 (profile A). The identification of peptide fragments was confirmed by N-terminal sequence analysis. References 1. Dodt, J., (1995) Angew. Chem. Int. Ed. Engl. 34, 867-880. 2. Scacheri, E., Nitti, G., Valsasina, B., Orsini, G., Visco, C., Ferrera, M., Sawyer, R.T., Sarmientos, P. (1993) Eur. J. Biochem. 214, 295-304. 3. Anicetti, V.R., Keyt, B.A., Hancock, W.S. (1989) Trends Biotechnol. 7, 342-348. Ordering Information 4. Markwardt, F. (1957), Hoppe-Seyler Z. Physiol. Chem. 308, 147-156. 5. Eckerskorn, C., Strupat, K., Karas, M., Hillenkamp, F., Lottspeich, F. (1992) Electrophoresis 13, 664-665. 6. Klarskov, K., Roepstorff, P. (1993) Biol. Mass. Spectrom. 22, 433-440. 7. Dunphy J. C., Busch, K. L., Hettich, R. L., Buchanan, M. V. (1993) Anal. Chem. 65, 1329-1335. 8. Righetti, P.G. (1990) Immobilized pH Gradients: Theory and Methodology, Elsevier, Amsterdam,. 9. Righetti, P.G., Wenisch, E., Faupel, M. (1989) J. Chromatogr. 475, 293-309. 10. Righetti, P.G., Wenisch, E., Jungbauer, A., Katinger, H., Faupel, M. (1990) J. Chromatogr. 500, 681-696. 11. Giaffreda, E., Tonani, C., Righetti, P.G. (1993) J. Chromatogr. 630, 313-327. 4 Code No. Item Description 80-6081-90 80-6082-47 18-1018-06 19-3500-01 80-1255-70 80-1255-71 80-1255-72 80-1255-73 80-1255-74 80-1255-75 IsoPrime Unit, 115 V IsoPrime Unit, 230 V Multiphor II Electrophoresis Unit EPS 3500 XL Power Supply Immobiline, 10 ml, pk 3.6 Immobiline, 10 ml, pk 4.6 Immobiline, 10 ml, pk 6.2 Immobiline, 10 ml, pk 7.0 Immobiline, 10 ml, pk 8.5 Immobiline, 10 ml, pk 9.3